Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRYSTAL trial of Y-6 sublingual tablets after reperfusion for acute ischemic stroke with large vessel occlusion
ChiCTR2400087944Phase 2Completed
- Sponsor
- Beijing Tiantan Hospital
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ischemic stroke comparing Y-6 Sublingual Tablet Group with Placebo Group (2 arms). Primary endpoint: Proportion with mRS 0 to 1 at 90 ± 7 days after randomization. Started Aug 2024; status: completed.
02
Drugs
cilostazol + dexborneol
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2400087944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400087944.